Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2006 Mar;31(3):651-8.
doi: 10.1038/sj.npp.1300886.

Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia

Affiliations
Randomized Controlled Trial

Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia

Shibley Rahman et al. Neuropsychopharmacology. 2006 Mar.

Abstract

The frontal variant of frontotemporal dementia is a significant neurological condition worldwide. There exist few treatments available for the cognitive and behavioural sequelae of fvFTD. Previous research has shown that these patients display risky decision-making, and numerous studies have now demonstrated pathology affecting the orbitofrontal cortex. The present study uses a within-subjects, double-blind, placebo-controlled procedure to investigate the effects of a single dose of methylphenidate (40 mg) upon a range of different cognitive processes including those assessing prefrontal cortex integrity. Methylphenidate was effective in 'normalizing' the decision-making behavior of patients, such that they became less risk taking on medication, although there were no significant effects on other aspects of cognitive function, including working memory, attentional set shifting, and reversal learning. Moreover, there was an absence of the normal subjective and autonomic responses to methylphenidate seen in elderly subjects. The results are discussed in terms of the 'somatic marker' hypothesis of impaired decision-making following orbitofrontal dysfunction.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Methylphenidate significantly reduced betting behavior on the Cambridge Gamble Task. Error bars indicate the standard errors of the mean. (b) The reduction in betting behavior in fvFTD patients on methylphenidate normalizes task performance, that is, performance approaches of healthy older adults. *Healthy data from the placebo condition of Turner et al (2003), in 20 male volunteers aged 55–69 years (mean age 61 years). (c) Individual data in the fvFTD group show that the reduction in betting is apparent in every subject.
Figure 2
Figure 2
Methylphenidate treatment did not significantly affect deliberation times (a) or choice of most likely outcome (b) on the Cambridge Gamble Task.

Similar articles

Cited by

References

    1. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci. 1986;9:357–381. - PubMed
    1. Aron AR, Dowson JH, Sahakian BJ, Robbins TW. Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2003;54:1465–1468. - PubMed
    1. Bartzokis G, Lu PH, Beckson M, Rapoport R, Grant S, Wiseman EJ, et al. Abstinence from cocaine reduces high-risk responses on a gambling task. Neuropsychopharmacology. 2000;22:102–103. - PubMed
    1. Bechara A. Emotion, decision-making and addiction. J Gamb Stud. 2003;19:23–51. - PubMed
    1. Bechara A, Damasio H, Damasio A. Manipulation of dopamine and serotonin causes different effects on covert and overt decision-making. Soc Neurosci Abstracts. 2001;27:456.5.

Publication types

MeSH terms

Substances